Clinical interests
Minimally invasive interventional care for benign and malignant liver, biliary and pancreatic diseases: interventional treatment of primary and metastatic liver cancer, including vascular embolization, catheter infusion and radiofrequency ablation, and conversion treatment followed by resection for unresectable giant or intermediate-to-advanced liver cancer; portal hypertension, bleeding from ruptured gastric fundal varices and refractory ascites; Budd–Chiari syndrome; second-stage liver resection induced by portal and hepatic venous system embolization; and minimally invasive treatment of hepatitis B, hepatitis, cirrhosis, liver nodules, gallstones, gallbladder polyps, hepatic hemangiomas and giant liver and kidney cysts.
Read more
Minimally invasive interventional care for benign and malignant liver, biliary and pancreatic diseases: interventional treatment of primary and metastatic liver cancer, including vascular embolization, catheter infusion and radiofrequency ablation, and conversion treatment followed by resection for unresectable giant or intermediate-to-advanced liver cancer; portal hypertension, bleeding from ruptured gastric fundal varices and refractory ascites; Budd–Chiari syndrome; second-stage liver resection induced by portal and hepatic venous system embolization; and minimally invasive treatment of hepatitis B, hepatitis, cirrhosis, liver nodules, gallstones, gallbladder polyps, hepatic hemangiomas and giant liver and kidney cysts.